Interim thymus and activation regulated chemokine versus interim 18 F‐fluorodeoxyglucose positron‐emission tomography in classical Hodgkin lymphoma response evaluation

Serum levels of TARC, MDC, IL10 and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study

(2019) Eric D. Hsi et al.   BLOOD

Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

(2017) Marc P.E. André et al.   JOURNAL OF CLINICAL ONCOLOGY

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

(2017) Peter Borchmann et al.   LANCET

Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma

(2017) A. Guidetti et al.   LEUKEMIA RESEARCH

Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC

(2016) Wouter J. Plattel et al.   BRITISH JOURNAL OF HAEMATOLOGY

Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalatedPlus Four Cycles of BEACOPPbaselinein Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial

(2016) Patrice Carde et al.   JOURNAL OF CLINICAL ONCOLOGY

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma

(2016) Peter Johnson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Biomarkers for atopic dermatitis

(2015) Judith Thijs et al.   Current Opinion in Allergy and Clinical Immunology

Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

(2015) John Radford et al.   NEW ENGLAND JOURNAL OF MEDICINE

In Vivo Treatment Sensitivity Testing With Positron Emission Tomography/Computed Tomography After One Cycle of Chemotherapy for Hodgkin Lymphoma

(2014) Martin Hutchings et al.   JOURNAL OF CLINICAL ONCOLOGY

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

(2014) Bruce D. Cheson et al.   JOURNAL OF CLINICAL ONCOLOGY

International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers

(2013) A. Biggi et al.   JOURNAL OF NUCLEAR MEDICINE

Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma

(2011) W. J. Plattel et al.   HAEMATOLOGICA

Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22

(2008) Marijke Niens et al.   BRITISH JOURNAL OF HAEMATOLOGY